Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: economics – Page 116

Investment in the fast-growing space industry was booming well into the first quarter of 2020 but private capital has largely frozen as the coronavirus pandemic strikes the U.S., leading both civil and military agencies to step up funding for corporate partners.

“We kicked into high gear as soon as it was apparent a lot of companies were not going to be able to conduct business as usual due to distancing requirements,” Mike Read, International Space Station business and economic development manager at NASA’s Johnson Space Center, told CNBC.

U.S. equity investment in space companies totaled $5.4 billion across 36 deals in the first quarter, according to a report Friday by NYC-based firm Space Capital. But the second quarter is likely to just see a fraction of that investment, according to Space Capital managing partner Chad Anderson, as deal flow in the U.S. will follow China’s path. Chinese investment in space was climbing by record amounts until the first quarter, when “activity in China was basically shut off,” Anderson said.

Read more | >

Ira Pastor, ideaXme life sciences ambassador, interviews Dr. Stanley Plotkin, Professor Emeritus at both Wistar Institute and the University of Pennsylvania and consultant to the vaccine industry.

Ira Pastor Comments:

So as we sit here a few months into the global covid-19 pandemic, one big question on everyone’s mind is when will we see the first mass produced vaccine against this current strain, especially as it looks like in the United States there will be some loosening of quarantine / “shelter in place” rules in the to re-start the economy.

Dr. Stanley Plotkin is an American physician, scientist, and scholar, in many circles referred to as the Godfather of Vaccines”, who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against Rubella virus (also known as German measles or three-day measles), which is now used worldwide (as a key component of the MMR vaccine — a combination vaccine also that protects against measles and mumps) and has worked extensively on the development and application of a wide range of other vaccines including polio, rabies, varicella, rotavirus and cytomegalovirus.

Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children’s Hospital of Philadelphia and at the Hospital for Sick Children in London.

Read more | >

We’re getting many calls and emails from WGN viewers who say they spotted a strange string of lights crossing the night sky on Sunday.

No, it’s not planes flying in formation or a meteor shower. It’s actually a satellite string that’s part of SpaceX’s “Starlink” project. You can read more about it below.

While much of the world economy stands still, SpaceX is running full speed ahead.

Read more | >

Even giant economic powerhouses have not been spared, with California—one of the wealthiest states in the United States thanks to its booming tech sector—having obliterated all its job growth over the last decade in just two months.

But now a renewable energy think-tank says directing those stimulus dollars to renewable energy investments could not only help tackle global climate emergency but spur massive economic gains post-Covid-19 for decades to come.

The International Renewable Energy Agency (IRENA) —an organization dedicated to promoting global adoption of renewable energy and facilitating sustainable use—says that it will cost the global economy $95 trillion to help return things to normal.

Read more | >

Download the full report here.

In 2017, Bellingcat and Transparency International UK published their joint report, “Offshore in the UK”, describing the phenomenon of Scottish Limited Partnerships (“SLPs”) and their use as a mechanism in global money laundering scandals and a range of illicit activities. Since then, SLPs have continued to be implicated in further scandals, perhaps most notably the Azerbaijani Laundromat, a scheme where $2.9 billion was laundered through UK companies.

In the same year, SLPs became obliged to register their Person of Significant Control at Companies House, and the boom in registrations ended. The government subsequently ran a public consultation into limited partnerships, and published its conclusions in December 2018. Currently, SLP registrations are at their lowest level since 2010. Nevertheless, a lack of regulation allowed thousands of opaquely owned partnerships, typically with no tangible link to the Uk, to flourish over a seven year period. We do not have the details of the business activities of these SLPs, who controlled them, or who their true beneficial owners are.

Read more | >

April 2020

The COVID-19 pandemic caused by SARS-CoV-2 has brought about an unprecedented crisis, taking a heavy toll on human health, lives as well as the global economy. There are no SARS-CoV-2-specific treatments or vaccines available due to the novelty of this virus. Hence, rapid development of effective vaccines against SARS-CoV-2 is urgently needed. Here we developed a pilot-scale production of a purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc), which induced SARS-CoV-2-specific neutralizing antibodies in mice, rats and non-human primates. These antibodies potently neutralized 10 representative SARS-CoV-2 strains, indicative of a possible broader neutralizing ability against SARS-CoV-2 strains circulating worldwide. Immunization with two different doses (3μg or 6 μg per dose) provided partial or complete protection in macaques against SARS-CoV-2 challenge, respectively, without any antibody-dependent enhancement of infection. Systematic evaluation of PiCoVacc via monitoring clinical signs, hematological and biochemical index, and histophathological analysis in macaques suggests that it is safe. These data support the rapid clinical development of SARS-CoV-2 vaccines for humans.

One Sentence Summary A purified inactivated SARS-CoV-2 virus vaccine candidate (PiCoVacc) confers complete protection in non-human primates against SARS-CoV-2 strains circulating worldwide by eliciting potent humoral responses devoid of immunopathology.

The authors have declared no competing interest.

Read more | >

Dinorah Delphin has unveiled another magnificent issue of the Immortalists Magazine. She has clearly focused her contributing authors on the world pandemic, with impressive results.

One of the outstanding articles is from our pal, the Chairman of the USTP, Gennady Stolyarov. Gennady levels an eviscerating attack on the American health care system.

I can see that Gennady has a visceral reaction to mass death. There is passionate, broiling anger in the lines of his article. He seems to be mounting a crusade, and I’m going to confess that I’m considering arming myself for battle.

“…there has not been the will…to prioritize public health and longevity as the overarching objective of the economy and of society.”

People have amazingly short attention spans. And you might think, after looking back at previous epidemics, that shortly after this subsides that everyone will go back to debating trivia on TV and quibbling over the latest inanities bellowed from the podium by the oompa loompa moron. After all are there vaccines for SARS, MERS, or HIV? No, there are not. It takes will and effort and money and focus and time to create an effective vaccine. I understand that the world record quickest vaccine development was for the mumps and that that effort took 4 years. However, this virus may have a second and a third wave coming, which might function as a nightmare wake-up alarm that can’t be shut off. There is the potential that at some point the mountainous pile of dead bodies will actually focus this nation’s attention on delivering a lasting solution. I credit Gennady for having the foresight to immediately engage the USTP in a series of proposals designed to enable that lasting solution.

What would our world look like if the number one priority was making everyone healthy enough to live forever?

Continue reading “IMMORTALISTS MAGAZINE’s 4th PUBLICATION!” | >

The economic impact of the coronavirus pandemic has governments struggling with how to restart a global economy that has come to a grinding halt. Some short term needs have to be addressed as soon as possible — avoiding starvation, extending unemployment benefits, and arranging for emergency healthcare for those infected. But even as the world faces such daunting tasks, decisions made today will have enormous consequences for the future. While the emergency today is great, a much bigger emergency waits just around the corner as the Earth continues to overheat.

Governments in thrall to fossil fuel interests, such as the United States, see the virus as a chance to roll back advances in renewable energy. After all, the oil and gas industries provide for 10,000,000 jobs around the world. Surely those jobs must be protected, right?

Read more | >

Alibaba’s founder Jack Ma said on Friday in a virtual interview with China Media Group that under the current situation of COVID-19, the internet economy is supporting the world and the internet is the technology of the future.

“No country or enterprises can be isolated from the internet,” Ma said, adding that every one of us must grasp the future and improve the country’s economic system through future technologies and ideas.

Read more | >

The main route of transmission of SARS CoV infection is presumed to be respiratory droplets. However the virus is also detectable in other body fluids and excreta. The stability of the virus at different temperatures and relative humidity on smooth surfaces were studied. The dried virus on smooth surfaces retained its viability for over 5 days at temperatures of 22–25°C and relative humidity of 40–50%, that is, typical air-conditioned environments. However, virus viability was rapidly lost (3 log10) at higher temperatures and higher relative humidity (e.g., 38°C, and relative humidity of 95%). The better stability of SARS coronavirus at low temperature and low humidity environment may facilitate its transmission in community in subtropical area (such as Hong Kong) during the spring and in air-conditioned environments. It may also explain why some Asian countries in tropical area (such as Malaysia, Indonesia or Thailand) with high temperature and high relative humidity environment did not have major community outbreaks of SARS.

Severe acute respiratory syndrome (SARS), was a new emerging disease associated with severe pneumonia and spread to involve over 30 countries in 5 continents in 2003. A novel coronavirus was identified as its cause [1–3]. SARS had a dramatic impact on health care services and economies of affected countries, and the overall mortality rate was estimated to be 9%, but rising to 50% in those aged 60 or above [4]. A notable feature of this disease was its predilection for transmission in the health care setting and to close family and social contacts. The disease is presumed to be spread by droplets, close direct or indirect contact, but the relative importance of these routes of transmission is presently unclear. A study showed that viral aerosol generation by a patient with SARS was possible and therefore airborne droplet transmission was a possible means of transmission [5].

Read more | >